S

Sensinnovat

Europe, Limburg, Belgium, Tessenderlo

Description

Sensinnovat invests in high-tech startups and other initiatives focused on improving people's lives and preserving the planet.

Investor Profile

Sensinnovat has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Seed (33%)

Country Focus

  • Belgium (67%)
  • France (33%)

Industry Focus

  • Diabetes
  • Health Care
  • Medical
  • Medical Device
  • Manufacturing
  • Nanotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sensinnovat frequently co-invest with?

Thuja Capital
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 2
PM
Europe, Oost-Vlaanderen, Belgium, Sint-martens-latem
Co-Investments: 2
SoFi
North America, California, United States, San Francisco
Co-Investments: 2
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Capricorn Partners
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
F
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
M
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Ackermans & van Haaren
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1

What are some of recent deals done by Sensinnovat?

Hummink

Paris, Ile-de-France, France

Hummink develops additive manufacturing technology designed to provide tools to design and manufacture at the nanoscale.

ManufacturingNanotechnology
SeedNov 15, 2022
Amount Raised: $5,178,750
Indigo Diabetes

Zwijnaarde, Oost-Vlaanderen, Belgium

Indigo Diabetes is a medtech company that develops a multi-biomarker sensor for people with diabetes.

DiabetesHealth CareMedicalMedical Device
Series BJul 27, 2020
Amount Raised: $44,724,088
Indigo Diabetes

Zwijnaarde, Oost-Vlaanderen, Belgium

Indigo Diabetes is a medtech company that develops a multi-biomarker sensor for people with diabetes.

DiabetesHealth CareMedicalMedical Device
Series ADec 20, 2016
Amount Raised: $7,273,559